Filing Details

Accession Number:
0000899243-18-007081
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-12 16:05:45
Reporting Period:
2018-03-12
Accepted Time:
2018-03-12 16:05:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626971 Corvus Pharmaceuticals Inc. CRVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1031847 Md A Richard Miller Corvus Pharmaceuticals, Inc.
863 Mitten Road, Suite 102
Burlingame CA 94010
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2018-03-12 100,000 $8.50 1,112,293 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Footnotes
  1. Reporting Person purchased 100,000 shares of Issuer's common stock in connection with a public offering at the offering price of $8.50 per share.
  2. A portion of these shares is subject to a right of repurchase held by the Issuer.
  3. These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.